Genegoggle Sp. z o.o. (Poland)

Genegoggle Sp. z o.o is a precision medicine biotech company. The company was founded to discover novel therapeutics and intelligent systems to improve human health by leveraging multi-dimensional genomic and epigenetic elements. Genegoggle uses biomedical approaches and artificial intelligence solutions to expand the current standard of care. Their team focuses on providing diagnostic tools, identifying epigenetic targets, and developing treatment solutions. The company offers services such as experimental design support, data analysis, and reporting for multi-omics experiments, with a focus on single-cell data analysis and spatial transcriptomics. Genegoggle's target market is projects focused on gene therapies and precise therapeutics. The company was founded to enhance the understanding of the human genome to support human health. Genegoggle's personalized approach is powered by artificial intelligence, and their team has expertise in epigenetics, computational biology, machine learning, software engineering, and data visualization. They use genetic and epigenetic profiles to characterize particular cell types and offer single-cell and spatial transcriptomics data analysis to support projects conducted by 10x Genomics.